back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-02 23:00 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$6,900
+15,000 vol $0.46 each |
42,000 | |
| Filed 2024-01-02 22:55 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,564
+3,400 vol $0.46 each |
257,000 | |
| Filed 2023-09-05 13:00 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,178
+3,300 vol $0.66 each |
253,600 | |
| Filed 2023-06-25 23:04 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,145
+3,300 vol $0.65 each |
250,300 | |
| Filed 2022-01-05 12:03 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+12,000 vol |
27,000 | |
| Filed 2022-01-05 11:27 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
247,000 | |
| Filed 2021-01-06 14:24 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+15,000 vol |
15,000 | |
| Filed 2021-01-06 14:23 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-06 13:05 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
235,000 | |
| Filed 2020-08-21 22:35 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,000
+20,000 vol $0.60 each |
225,000 | |
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
205,000 | |
| Filed 2018-06-22 Tx date 2018-06-15 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,811.625
-11,250 vol $0.4277 each |
180,000 | |
| Filed 2018-06-22 Tx date 2018-06-15 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,811
+11,250 vol $0.4277 each |
39,384 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
191,250 | |
| Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
151,250 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
111,250 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
11,250 | ||
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
28,134 |